These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33870635)

  • 1. MELD is MELD is MELD? Transplant center-level variation in waitlist mortality for candidates with the same biological MELD.
    Ishaque T; Kernodle AB; Motter JD; Jackson KR; Chiang TP; Getsin S; Boyarsky BJ; Garonzik-Wang J; Gentry SE; Segev DL; Massie AB
    Am J Transplant; 2021 Oct; 21(10):3305-3311. PubMed ID: 33870635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease.
    Nadim MK; DiNorcia J; Ji L; Groshen S; Levitsky J; Sung RS; Kim WR; Andreoni K; Mulligan D; Genyk YS
    J Hepatol; 2017 Sep; 67(3):517-525. PubMed ID: 28483678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Share 21 model in liver transplantation: Impact on waitlist outcomes.
    Nagai S; Chau LC; Kitajima T; Yeddula S; Collins K; Rizzari M; Yoshida A; Abouljoud MS; Moonka D
    Am J Transplant; 2020 Aug; 20(8):2184-2197. PubMed ID: 32155314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.
    Gadiparthi C; Cholankeril G; Yoo ER; Hu M; Wong RJ; Ahmed A
    Dig Dis Sci; 2018 Jun; 63(6):1647-1653. PubMed ID: 29611079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Body Surface Area With Access to Deceased Donor Liver Transplant and Novel Allocation Policies.
    Kling CE; Biggins SW; Bambha KM; Feld LD; Perkins JH; Reyes JD; Perkins JD
    JAMA Surg; 2023 Jun; 158(6):610-616. PubMed ID: 36988928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality in patients with end-stage liver disease above model for end-stage liver disease 3.0 of 40.
    Kim WR; Mannalithara A; Kwo PY; Bonham CA; Kwong A
    Hepatology; 2023 Mar; 77(3):851-861. PubMed ID: 36052665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Awarding additional MELD points to the shortest waitlist candidates improves sex disparity in access to liver transplant in the United States.
    Bernards S; Lee E; Leung N; Akan M; Gan K; Zhao H; Sarkar M; Tayur S; Mehta N
    Am J Transplant; 2022 Dec; 22(12):2912-2920. PubMed ID: 35871752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Waitlist Outcomes of Liver Transplant Candidates Who Were Reprioritized Under Share 35.
    Chow EK; Massie AB; Luo X; Wickliffe CE; Gentry SE; Cameron AM; Segev DL
    Am J Transplant; 2017 Feb; 17(2):512-518. PubMed ID: 27457221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Allocating Livers for Transplantation Based on Model for End-Stage Liver Disease-Sodium Scores on Patient Outcomes.
    Nagai S; Chau LC; Schilke RE; Safwan M; Rizzari M; Collins K; Yoshida A; Abouljoud MS; Moonka D
    Gastroenterology; 2018 Nov; 155(5):1451-1462.e3. PubMed ID: 30056096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a Korean Liver Allocation System using Model for End Stage Liver Disease Scores: A Nationwide, Multicenter study.
    Lee J; Lee JG; Jung I; Joo DJ; Kim SI; Kim MS;
    Sci Rep; 2019 May; 9(1):7495. PubMed ID: 31097768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of major hepatocellular carcinoma policy changes on liver transplantation for hepatocellular carcinoma in the United States.
    Shah RH; Chyou D; Goldberg DS
    Liver Transpl; 2022 Dec; 28(12):1857-1864. PubMed ID: 35585774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Offer Acceptance Patterns for Liver Donors Aged 70 and Older.
    Haugen CE; Bowring MG; Jackson KR; Garonzik-Wang J; Massie AB; Chiang TP; Philosophe B; Segev DL; Halazun KJ
    Liver Transpl; 2022 Apr; 28(4):571-580. PubMed ID: 34559954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting Outcomes on the Liver Transplant Waiting List in the United States: Accounting for Large Regional Variation in Organ Availability and Priority Allocation Points.
    Hart A; Schladt DP; Zeglin J; Pyke J; Kim WR; Lake JR; Roberts JP; Hirose R; Mulligan DC; Kasiske BL; Snyder JJ; Israni AK
    Transplantation; 2016 Oct; 100(10):2153-9. PubMed ID: 27490411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of MELD on waitlist outcome of retransplant candidates.
    Kim HJ; Larson JJ; Lim YS; Kim WR; Pedersen RA; Therneau TM; Rosen CB
    Am J Transplant; 2010 Dec; 10(12):2652-7. PubMed ID: 21070603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reassessing the survival benefit of deceased donor liver transplantation: retrospective cohort study.
    Malamon JS; Kaplan B; Jackson WE; Saben JL; Schold JD; Pomfret EA; Pomposelli JJ
    Int J Surg; 2023 Sep; 109(9):2714-2720. PubMed ID: 37226874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplant center variability in utilizing nonstandard donors and its impact on the transplantation of patients with lower MELD scores.
    Goldberg DS; McKenna GJ
    Liver Transpl; 2024 May; 30(5):461-471. PubMed ID: 37902549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MELD 3.0 for adolescent liver transplant candidates.
    Kwong AJ; Zhang KY; Ebel N; Mannalithara A; Kim WR
    Hepatology; 2023 Aug; 78(2):540-546. PubMed ID: 36943091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should All Status 1A Patients Be Prioritized Over High MELD Patients? Concept of Risk Stratification in Extremely Ill Liver Transplant Recipients.
    Safwan M; Nwagu U; Collins K; Abouljoud M; Nagai S
    Transplantation; 2019 Oct; 103(10):2121-2129. PubMed ID: 30747840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MELD as a metric for survival benefit of liver transplantation.
    Luo X; Leanza J; Massie AB; Garonzik-Wang JM; Haugen CE; Gentry SE; Ottmann SE; Segev DL
    Am J Transplant; 2018 May; 18(5):1231-1237. PubMed ID: 29316310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved Waitlist Outcomes in Liver Transplant Patients With Mid-MELD-Na Scores Listed in Centers Receptive to Use of Organs Donated After Circulatory Death.
    Miyake K; Chau LC; Trudeau S; Kitajima T; Wickramaratne N; Shimada S; Nassar A; Gonzalez HC; Venkat D; Moonka D; Yoshida A; Abouljoud MS; Nagai S
    Transplantation; 2024 Sep; 108(9):1943-1953. PubMed ID: 38409687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.